Author:
Haber Craig,Kwiterovich Peter O.
Abstract
Abstract: The cutaneous markers associated with dyslipoproteinemia are reviewed in the context of the current view of lipid and lipoprotein metabolism. The utility of determining the plasma levels of lipoprotcins and certain apoproteins in children or adults with xanthomas or xanthelasma is discussed. We hope that early identification and appropriate treatment of such patients will reduce the morbidity and mortality from the two major complications of dyslipoproteinemia—atherosclerotic cardiovascular disease and pancreatitis.
Reference90 articles.
1. Co‐operative trial in primary prevention of ischemic heart disease using clofibrate;Oliver MF;Br Heart J,1979
2. National Institutes of Health Secondary Prevention Trial in type II hyperlipoproteinemia.Circulation1984 in press.
3. The Lipid Research Clinics Coronary Primary Prevention Trial Results
4. Treatment of Hypercholesterolemia
5. Clofibrate niacin in coronary heart disease;Coronary Drug Project Research Group;JAMA,1975
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献